Skip to main content
Erschienen in: European Radiology 7/2019

21.03.2019 | Magnetic Resonance

Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis

verfasst von: Jiulian Gu, Shousheng Liu, Shuixian Du, Qing Zhang, Jianhan Xiao, Quanjiang Dong, Yongning Xin

Erschienen in: European Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To systematically review studies about the diagnostic accuracy of magnetic resonance imaging proton density fat fraction (MRI-PDFF) in the classification of hepatic steatosis grade in patients with non-alcoholic fatty liver disease (NAFLD).

Methods

Areas under the summary receiver operating characteristic curves (AUROC), sensitivity, specificity, overall diagnostic odds ratio (DOR), diagnostic score, positive likelihood ratio (+LR), and negative likelihood ratio (−LR) for MRI-PDFF in classification of steatosis grades 0 vs. 1–3, 0–1 vs. 2–3, and 0–2 vs. 3 were compared and analyzed.

Results

A total of 6 studies were included in this meta-analysis (n = 635). The summary AUROC values of MRI-PDFF for classifying steatosis grades 0 vs. 1–3, 0–1 vs. 2–3, and 0–2 vs. 3 were 0.98, 0.91, and 0.90, respectively. Pooled sensitivity and specificity of MRI-PDFF for classifying steatosis grades 0 vs. 1–3, 0–1 vs. 2–3, and 0–2 vs. 3 were 0.93 and 0.94, 0.74 and 0.90, and 0.74 and 0.87, respectively. Summary +LR and −LR of MRI-PDFF for classifying steatosis grades 0 vs. 1–3, 0–1 vs. 2–3, and 0–2 vs. 3 were 16.21 (95%CI, 4.72–55.67) and 0.08 (95%CI, 0.04–0.15), 7.19 (95%CI, 5.04–10.26) and 0.29 (95%CI, 0.22–0.38), and 5.89 (95%CI, 4.27–8.13) and 0.29 (95%CI, 0.21–0.41), respectively.

Conclusions

Our meta-analysis suggests that MRI-PDFF has excellent diagnostic value for assessment of hepatic fat content and classification of histologic steatosis in patients with NAFLD.

Key Points

MRI-PDFF has significant diagnostic value for hepatic steatosis in patients with NAFLD.
MRI-PDFF may be used to classify grade of hepatic steatosis with high sensitivity and specificity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690CrossRefPubMed Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690CrossRefPubMed
2.
Zurück zum Zitat Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161CrossRefPubMed Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161CrossRefPubMed
3.
Zurück zum Zitat Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393CrossRefPubMed Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393CrossRefPubMed
4.
Zurück zum Zitat Alswat K, Aljumah AA, Sanai FM et al (2018) Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017–2030. Saudi J Gastroenterol 24:211–219CrossRefPubMedPubMedCentral Alswat K, Aljumah AA, Sanai FM et al (2018) Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017–2030. Saudi J Gastroenterol 24:211–219CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. Jama 313:2263–2273CrossRefPubMed Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. Jama 313:2263–2273CrossRefPubMed
6.
Zurück zum Zitat Alexander J, Torbenson M, Wu TT, Yeh MM (2013) Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 28:848–854CrossRefPubMed Alexander J, Torbenson M, Wu TT, Yeh MM (2013) Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 28:848–854CrossRefPubMed
7.
Zurück zum Zitat Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R (2015) Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13:643–654 e641–649; quiz e639–640CrossRefPubMed Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R (2015) Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13:643–654 e641–649; quiz e639–640CrossRefPubMed
8.
10.
Zurück zum Zitat Cadranel JF (2002) [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. Gastroenterol Clin Biol 26:823–824 Cadranel JF (2002) [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. Gastroenterol Clin Biol 26:823–824
11.
Zurück zum Zitat Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral Bonekamp S, Tang A, Mashhood A et al (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39:1525–1532CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Merriman RB, Ferrell LD, Patti MG et al (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44:874–880CrossRefPubMed Merriman RB, Ferrell LD, Patti MG et al (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44:874–880CrossRefPubMed
13.
Zurück zum Zitat Idilman IS, Ozdeniz I, Karcaaltincaba M (2016) Hepatic steatosis: etiology, patterns, and quantification. Semin Ultrasound CT MR 37:501–510CrossRefPubMed Idilman IS, Ozdeniz I, Karcaaltincaba M (2016) Hepatic steatosis: etiology, patterns, and quantification. Semin Ultrasound CT MR 37:501–510CrossRefPubMed
14.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed
15.
Zurück zum Zitat Park CC, Nguyen P, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598–607 e592CrossRefPubMed Park CC, Nguyen P, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598–607 e592CrossRefPubMed
16.
Zurück zum Zitat Hashimoto E, Taniai M, Tokushige K (2013) Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol 28(Suppl 4):64–70CrossRefPubMed Hashimoto E, Taniai M, Tokushige K (2013) Characteristics and diagnosis of NAFLD/NASH. J Gastroenterol Hepatol 28(Suppl 4):64–70CrossRefPubMed
17.
Zurück zum Zitat Alisi A, Pinzani M, Nobili V (2009) Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology 50:2048–2049 author reply 2049-2050CrossRefPubMed Alisi A, Pinzani M, Nobili V (2009) Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology 50:2048–2049 author reply 2049-2050CrossRefPubMed
18.
Zurück zum Zitat Chan WK, Nik Mustapha NR, Mahadeva S (2014) Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 29:1470–1476CrossRefPubMed Chan WK, Nik Mustapha NR, Mahadeva S (2014) Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 29:1470–1476CrossRefPubMed
19.
Zurück zum Zitat Schwimmer JB, Middleton MS, Deutsch R, Lavine JE (2005) A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21:871–879CrossRefPubMed Schwimmer JB, Middleton MS, Deutsch R, Lavine JE (2005) A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21:871–879CrossRefPubMed
20.
Zurück zum Zitat Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRefPubMedPubMedCentral Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Reeder SB (2013) Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 58:1877–1880CrossRefPubMed Reeder SB (2013) Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 58:1877–1880CrossRefPubMed
22.
Zurück zum Zitat Le TA, Chen J, Changchien C et al (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56:922–932CrossRefPubMed Le TA, Chen J, Changchien C et al (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56:922–932CrossRefPubMed
23.
Zurück zum Zitat Bannas P, Kramer H, Hernando D et al (2015) Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62:1444–1455CrossRefPubMed Bannas P, Kramer H, Hernando D et al (2015) Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62:1444–1455CrossRefPubMed
24.
Zurück zum Zitat Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431CrossRefPubMedPubMedCentral Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422–431CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kim M, Kang BK, Jun DW (2018) Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis. Sci Rep 8:7759CrossRefPubMedPubMedCentral Kim M, Kang BK, Jun DW (2018) Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis. Sci Rep 8:7759CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Loomba R, Kayali Z, Noureddin M et al (2018) GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease. Gastroenterology Loomba R, Kayali Z, Noureddin M et al (2018) GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease. Gastroenterology
27.
Zurück zum Zitat Patel NS, Peterson MR, Lin GY et al (2013) Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterol Res Pract 2013:498296CrossRefPubMedPubMedCentral Patel NS, Peterson MR, Lin GY et al (2013) Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterol Res Pract 2013:498296CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Idilman IS, Tuzun A, Savas B et al (2015) Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging 40:1512–1519CrossRefPubMed Idilman IS, Tuzun A, Savas B et al (2015) Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging 40:1512–1519CrossRefPubMed
29.
Zurück zum Zitat Yu NY, Wolfson T, Middleton MS et al (2017) Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. Clin Radiol 72:425.e429–425.e414 Yu NY, Wolfson T, Middleton MS et al (2017) Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. Clin Radiol 72:425.e429–425.e414
30.
Zurück zum Zitat Runge JH, Bakker PJ, Gaemers IC et al (2014) Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology. MAGMA 27:317–327CrossRefPubMed Runge JH, Bakker PJ, Gaemers IC et al (2014) Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology. MAGMA 27:317–327CrossRefPubMed
31.
Zurück zum Zitat Ueno T, Suzuki H, Hiraishi M, Amano H, Fukuyama H, Sugimoto N (2016) In vivo magnetic resonance microscopy and hypothermic anaesthesia of a disease model in Medaka. Sci Rep 6:27188CrossRefPubMedPubMedCentral Ueno T, Suzuki H, Hiraishi M, Amano H, Fukuyama H, Sugimoto N (2016) In vivo magnetic resonance microscopy and hypothermic anaesthesia of a disease model in Medaka. Sci Rep 6:27188CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Schueler S, Schuetz GM, Dewey M (2012) The revised QUADAS-2 tool. Ann Intern Med 156:323 author reply 323-324CrossRefPubMed Schueler S, Schuetz GM, Dewey M (2012) The revised QUADAS-2 tool. Ann Intern Med 156:323 author reply 323-324CrossRefPubMed
33.
Zurück zum Zitat Imajo K, Kessoku T, Honda Y et al (2016) Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150:626–637.e627CrossRefPubMed Imajo K, Kessoku T, Honda Y et al (2016) Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150:626–637.e627CrossRefPubMed
34.
Zurück zum Zitat Middleton MS, Van Natta ML, Heba ER et al (2017) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67:858–872CrossRef Middleton MS, Van Natta ML, Heba ER et al (2017) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67:858–872CrossRef
35.
Zurück zum Zitat Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761CrossRefPubMed
36.
Zurück zum Zitat Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425CrossRefPubMed Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416–425CrossRefPubMed
37.
Zurück zum Zitat Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRefPubMed Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRefPubMed
38.
39.
Zurück zum Zitat Kim SH, Lee JM, Han JK et al (2006) Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings. Radiology 240:116–129CrossRefPubMed Kim SH, Lee JM, Han JK et al (2006) Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings. Radiology 240:116–129CrossRefPubMed
40.
Zurück zum Zitat Fernandez-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM (2011) Percutaneous liver biopsy: patients’ point of view. Scand J Gastroenterol 46:727–731CrossRefPubMed Fernandez-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM (2011) Percutaneous liver biopsy: patients’ point of view. Scand J Gastroenterol 46:727–731CrossRefPubMed
41.
Zurück zum Zitat Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906CrossRefPubMed Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906CrossRefPubMed
42.
Zurück zum Zitat d’Assignies G, Paisant A, Bardou-Jacquet E et al (2018) Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol 28:2022–2030CrossRefPubMed d’Assignies G, Paisant A, Bardou-Jacquet E et al (2018) Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol 28:2022–2030CrossRefPubMed
43.
Zurück zum Zitat Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRefPubMedPubMedCentral Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759CrossRefPubMedPubMedCentral Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749–759CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Di Martino M, Pacifico L, Bezzi M et al (2016) Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol 22:8812–8819CrossRefPubMedPubMedCentral Di Martino M, Pacifico L, Bezzi M et al (2016) Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol 22:8812–8819CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Noureddin M, Lam J, Peterson MR et al (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58:1930–1940CrossRefPubMed Noureddin M, Lam J, Peterson MR et al (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58:1930–1940CrossRefPubMed
47.
Zurück zum Zitat Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68:763–772CrossRefPubMed Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68:763–772CrossRefPubMed
48.
Zurück zum Zitat Friedrich-Rust M, Romen D, Vermehren J et al (2012) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 81:e325–e331CrossRefPubMed Friedrich-Rust M, Romen D, Vermehren J et al (2012) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 81:e325–e331CrossRefPubMed
49.
Zurück zum Zitat Cassinotto C, Boursier J, de Ledinghen V et al (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63:1817–1827CrossRefPubMed Cassinotto C, Boursier J, de Ledinghen V et al (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology 63:1817–1827CrossRefPubMed
50.
Zurück zum Zitat Woo H, Lee JY, Yoon JH, Kim W, Cho B, Choi BI (2015) Comparison of the reliability of acoustic radiation force impulse imaging and supersonic shear imaging in measurement of liver stiffness. Radiology 277:881–886CrossRefPubMed Woo H, Lee JY, Yoon JH, Kim W, Cho B, Choi BI (2015) Comparison of the reliability of acoustic radiation force impulse imaging and supersonic shear imaging in measurement of liver stiffness. Radiology 277:881–886CrossRefPubMed
51.
Zurück zum Zitat Ferraioli G, Tinelli C, Lissandrin R et al (2014) Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 20:4787–4796CrossRefPubMedPubMedCentral Ferraioli G, Tinelli C, Lissandrin R et al (2014) Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 20:4787–4796CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Ma JJ, Ding H, Mao F, Sun HC, Xu C, Wang WP (2014) Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results. J Gastroenterol Hepatol 29:814–819CrossRefPubMed Ma JJ, Ding H, Mao F, Sun HC, Xu C, Wang WP (2014) Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results. J Gastroenterol Hepatol 29:814–819CrossRefPubMed
53.
Zurück zum Zitat Fraquelli M, Baccarin A, Casazza G et al (2016) Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease. Aliment Pharmacol Ther 44:356–365CrossRefPubMed Fraquelli M, Baccarin A, Casazza G et al (2016) Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease. Aliment Pharmacol Ther 44:356–365CrossRefPubMed
54.
Zurück zum Zitat Conti F, Serra C, Vukotic R et al (2017) Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int 37:187–195CrossRefPubMed Conti F, Serra C, Vukotic R et al (2017) Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int 37:187–195CrossRefPubMed
55.
Zurück zum Zitat Mare R, Sporea I, Lupusoru R et al (2017) The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies. Ultrasonics 77:144–151CrossRefPubMed Mare R, Sporea I, Lupusoru R et al (2017) The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies. Ultrasonics 77:144–151CrossRefPubMed
56.
Zurück zum Zitat Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775CrossRefPubMed Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775CrossRefPubMed
57.
Zurück zum Zitat McPherson S, Jonsson JR, Cowin GJ et al (2009) Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 51:389–397CrossRefPubMed McPherson S, Jonsson JR, Cowin GJ et al (2009) Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 51:389–397CrossRefPubMed
Metadaten
Titel
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
verfasst von
Jiulian Gu
Shousheng Liu
Shuixian Du
Qing Zhang
Jianhan Xiao
Quanjiang Dong
Yongning Xin
Publikationsdatum
21.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06072-4

Weitere Artikel der Ausgabe 7/2019

European Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.